Suchergebnisse - "Creveuil, Christian"

PubPharm (7)

1

VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Levallet, G. | Dubois, F. | Elie, N. | +16

2

A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial

enthalten in: International journal of cancer | 2022

von Maille, E. | Levallet, J. | Dubois, F. | +17

3

MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial

enthalten in: British journal of cancer | 2019

von Maille, E. | Brosseau, S. | Hanoux, V. | +17

4

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS) : a randomised, controlled, open-label, phase 3 trial

enthalten in: Lancet (London, England) | 2016

von Zalcman, G. | Mazieres, J. | Margery, J. | +19

CommentIn: Lancet. 2016 Apr 2;387(10026):1352-4. - PMID 26719231

5

An apoptosis methylation prognostic signature for early lung cancer in the IFCT-0002 trial

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2012

von de Fraipont, F. | Levallet, G. | Creveuil, C. | +118

6

High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway

enthalten in: Molecular cancer therapeutics | 2012

von Levallet, G. | Bergot, E. | Antoine, M. | +18

7

Maggot therapy for wound debridement : a randomized multicenter trial

enthalten in: Archives of dermatology | 2012

von Opletalová, K. | Blaizot, X. | Mourgeon, B. | +6

1
[1]